Takhzyro

(lanadelumab-flyo)
NO BOXED WARNING

Dosage & Administration

For subcutaneous use only.

Recommended Dosage:

Get Your Patient on Takhzyro

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Takhzyro Prescribing Information

Takhzyro Prior Authorization Resources

Most recent Takhzyro prior authorization forms

Most recent state uniform prior authorization forms

Takhzyro PubMed™ News

5 most recent articles for Takhzyro, view all articles on PubMed™
Show the latest PubMed™ articles for Takhzyro